CISplatin
- Strength
- 1 mg/mL
- Form
- Injection, Solution
- Class
- Platinum-based Drug
WG Critical Care, LLC
Listed by WG Critical Care, LLC
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Platinum-based Drug |
| Approval route | NDA — original brand approval |
| NDC code | 44567-530 |
| FDA application | NDA018057 |
| RxNorm concept | 1736854 |
| Package sizes listed | 1 |
| Marketed since | April 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
WG Critical Care, LLC
Teva Parenteral Medicines, Inc.
Accord Healthcare Inc.
Hikma Pharmaceuticals USA Inc.
BluePoint Laboratories
BluePoint Laboratories
Sagent Pharmaceuticals
Apotex Corp.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.